01652nam 2200385Ia 450 991069886880332120090512090534.0(CKB)5470000002397176(OCoLC)320813893(EXLCZ)99547000000239717620090512d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for clinical investigators, institutional review boards, and sponsors[electronic resource] process for handling referrals to FDA under 21 CFR 50.54 : additional safeguards for children in clinical investigationsRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration,[2006]i, 9 pages digital, PDF fileTitle from PDF title page (viewed on May 12, 2009)."December 2006".Guidance for clinical investigators, institutional review boards, and sponsors Medical research personnelGovernment policyUnited StatesClinical trialsGovernment policyUnited StatesPediatricsResearchGovernment policyUnited StatesMedical research personnelGovernment policyClinical trialsGovernment policyPediatricsResearchGovernment policyUnited States.Food and Drug Administration.GPOGPOBOOK9910698868803321Guidance for clinical investigators, institutional review boards, and sponsors3502728UNINA